Financial Reports

INVESTORS

Quarterly and annual financial statements + Management's Discussion & Analysis. All filings posted to SEDAR+ (Canadian regulatory filing system).

2025

4 filings

Period	Filed	Financial Statements	MD&A
AnnualAudited	December 30, 2025	FS	MD&A
Q3Interim	September 30, 2025	FS	MD&A
Q2Interim	June 30, 2025	FS	MD&A
Q1Interim	March 30, 2025	FS	MD&A

2024

4 filings

Period	Filed	Financial Statements	MD&A
AnnualAudited	December 30, 2024	FS	MD&A
Q3Interim	September 30, 2024	FS	MD&A
Q2Interim	June 30, 2024	FS	MD&A
Q1Interim	March 30, 2024	FS	MD&A

2023

4 filings

Period	Filed	Financial Statements	MD&A
AnnualAudited	December 30, 2023	FS	MD&A
Q3Interim	September 30, 2023	FS	MD&A
Q2Interim	June 30, 2023	FS	MD&A
Q1Interim	March 30, 2023	FS	MD&A

2022

4 filings

Period	Filed	Financial Statements	MD&A
AnnualAudited	December 30, 2022	FS	MD&A
Q3Interim	September 30, 2022	FS	MD&A
Q2Interim	June 30, 2022	FS	MD&A
Q1Interim	March 30, 2022	FS	MD&A

2021

4 filings

Period	Filed	Financial Statements	MD&A
AnnualAudited	December 30, 2021	FS	—
Q3Interim	September 30, 2021	FS	MD&A
Q2Interim	June 30, 2021	FS	MD&A
Q1Interim	March 30, 2021	FS	MD&A

2020

4 filings

Period	Filed	Financial Statements	MD&A
AnnualAudited	December 30, 2020	FS	MD&A
Q3Interim	September 30, 2020	FS	MD&A
Q2Interim	June 30, 2020	FS	MD&A
Q1Interim	March 30, 2020	FS	MD&A

2019

4 filings

Period	Filed	Financial Statements	MD&A
AnnualAudited	December 30, 2019	FS	MD&A
Q3Interim	September 30, 2019	FS	MD&A
Q2Interim	June 30, 2019	FS	MD&A
Q1Interim	March 30, 2019	FS	MD&A

2018

4 filings

Period	Filed	Financial Statements	MD&A
AnnualAudited	December 30, 2018	FS	MD&A
Q3Interim	September 30, 2018	FS	MD&A
Q2Interim	June 30, 2018	FS	MD&A
Q1Interim	March 30, 2018	FS	MD&A

2017

4 filings

Period	Filed	Financial Statements	MD&A
AnnualAudited	December 30, 2017	FS	MD&A
Q3Interim	September 30, 2017	FS	MD&A
Q2Interim	June 30, 2017	FS	MD&A
Q1Interim	March 30, 2017	FS	MD&A

2016

4 filings

Period	Filed	Financial Statements	MD&A
AnnualAudited	December 30, 2016	FS	MD&A
Q3Interim	September 30, 2016	FS	MD&A
Q2Interim	June 30, 2016	FS	MD&A
Q1Interim	March 30, 2016	FS	MD&A

2015

3 filings

Period	Filed	Financial Statements	MD&A
AnnualAudited	December 30, 2015	FS	MD&A
Q3Interim	September 30, 2015	FS	MD&A
Q2Interim	June 30, 2015	—	MD&A

HISTORICAL DISCLOSURE

CSE Form 7 Monthly Progress Reports (2017–2020)

Filed during RIWI's prior listing on the Canadian Securities Exchange before graduating to TSX Venture. Retained for completeness of public filing history.

View 32 historical CSE Form 7 monthly reports (2017–2020)▾

These reports were filed under CSE Policy 6 during RIWI’s listing on the Canadian Securities Exchange prior to graduating to the TSX Venture Exchange. They are retained for historical disclosure access.

QUESTIONS?

Talk to Investor Relations.

Email investors@riwi.com for additional financial information or analyst inquiries.

Email IRView on SEDAR+

Insight Engine

Audience access

Verification